Skip to content
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
align-justify
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
user-group
INVESTOR ACCESS
Search
apps
Home
About us
Team
Investments
Investor Relations
Sustainability
News
Meet us
Home
/
Venture Capital
/
MRM Health Reports Preclinical...
Venture Capital
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
6 June 2022
Download
Press Release
Download
Related News
Buyout
Buyout
February 12, 2026
Mérieux Equity Partners acquires a significant minority stake in Health in Code
arrow-up-right
Buyout
Buyout
December 15, 2025
Mérieux Equity Partners Announces Agreement to Sell Majority of its Stake in Swixx Biopharma.
arrow-up-right
Buyout
Buyout
October 16, 2025
Nactarome Group joins forces with Plantex, strengthening their presence in plant extracts.
arrow-up-right
